Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Cleverly AL"'
Autor:
Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, Slapak CA, Lahn MM
Publikováno v:
Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 4479-4499 (2015)
Stephan Herbertz,1 J Scott Sawyer,2 Anja J Stauber,2 Ivelina Gueorguieva,3 Kyla E Driscoll,4 Shawn T Estrem,2 Ann L Cleverly,3 Durisala Desaiah,2 Susan C Guba,2 Karim A Benhadji,2 Christopher A Slapak,2 Michael M Lahn21Lilly Deutschland GmbH, Bad Hom
Externí odkaz:
https://doaj.org/article/7528a401427b41a9904e8212050c3fe0
Autor:
Simon GR, Ilaria RL Jr, Sovak MA, Williams CC, Haura EB, Cleverly AL, Sykes AK, Wagner MM, de Alwis DP, Slapak CA, Miller MA, Spriggs DR, Simon, George R, Ilaria, Robert L Jr, Sovak, Mika A, Williams, Charles C, Haura, Eric B, Cleverly, Ann L, Sykes, Amanda K, Wagner, Margaret M
Publikováno v:
Cancer Chemotherapy & Pharmacology; Nov2011, Vol. 68 Issue 5, p1233-1241, 9p
Publikováno v:
Journal of Clinical Pharmacology; Sep2007, Vol. 47 Issue 9, p1138-1151, 14p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wick A; Clinical Cooperation Unit Neuro-oncology, German Cancer Research Center, Heidelberg University Medical Center, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. antje.wick@med.uni-heidelberg.de., Desjardins A; The Preston Robert Tisch Brain Tumor Center at Duke, Duke University, Durham, NC, USA., Suarez C; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Forsyth P; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Gueorguieva I; Eli Lilly and Company, Erl Wood, UK., Burkholder T; Eli Lilly and Company, Indianapolis, IN, USA., Cleverly AL; Eli Lilly and Company, Erl Wood, UK., Estrem ST; Eli Lilly and Company, Indianapolis, IN, USA., Wang S; BioStat Solutions, Inc, Frederick, MD, USA., Lahn MM; Eli Lilly and Company, Indianapolis, IN, USA., Guba SC; Eli Lilly and Company, Indianapolis, IN, USA., Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Rodon J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, U. T. M. D. Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2020 Oct; Vol. 38 (5), pp. 1570-1579. Date of Electronic Publication: 2020 Mar 05.
Autor:
Santini V; MDS Unit, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy. amit.verma@einstein.yu.edu valeria.santini@unifi.it., Valcárcel D; Department of Hematology, Vall d'Hebrón University Hospital, Barcelona, Spain., Platzbecker U; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Cleverly AL; Eli Lilly and Company, Erl Wood, United Kingdom., Lahn MM; Eli Lilly and Company, Indianapolis, Indiana., Janssen J; Onkologische Gemeinschaftspraxis, Westerstede, Germany., Zhao Y; Eli Lilly and Company, Indianapolis, Indiana., Chiang A; Eli Lilly and Company, Indianapolis, Indiana., Giagounidis A; Clinic for Hematology, Oncology and Palliative Care, Marienhospital, Düsseldorf, Germany., Guba SC; Eli Lilly and Company, Indianapolis, Indiana., Gueorguieva I; Eli Lilly and Company, Erl Wood, United Kingdom., Girvan AC; Eli Lilly and Company, Indianapolis, Indiana., da Silva Ferreira M; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Bhagat TD; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Pradhan K; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Steidl U; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Sridharan A; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Will B; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Verma A; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York. amit.verma@einstein.yu.edu valeria.santini@unifi.it.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 01; Vol. 25 (23), pp. 6976-6985. Date of Electronic Publication: 2019 Sep 03.
Autor:
Kovacs RJ; Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. rikovacs@iupui.edu., Maldonado G; Department of Cardiology, Vall d'Hebron, Barcelona, Spain. giulymaldonado@hotmail.com., Azaro A; Medical Oncology, Vall d'Hebron, Barcelona, Spain. a.azaro@vhebron.net., Fernández MS; Department of Cardiology, Hospital Universitario 12 de Octubre, Madrid, Spain. sfcasares@gmail.com., Romero FL; Department of Cardiology, Hospital Universitario 12 de Octubre, Madrid, Spain. flombera@yahoo.es., Sepulveda-Sánchez JM; Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. jmsepulveda76@gmail.com., Corretti M; Division of Cardiology, Johns Hopkins University, Baltimore, MD, 21218, USA. mcorret1@jhmi.edu., Carducci M; Johns Hopkins Kimmel Cancer Center, Baltimore, MD, 21218, USA. carducci@jhmi.edu., Dolan M; Department of Cardiology and Cardiovascular Disease, Saint Louis University Hospital, St. Louis, MO, 63103, USA. melda@tetranet.net., Gueorguieva I; Eli Lilly and Company, Erl Wood, UK. gueorguieva_ivelina@lilly.com., Cleverly AL; Eli Lilly and Company, Erl Wood, UK. cleverly_ann_louise@lilly.com., Pillay NS; Eli Lilly and Company, Building 31/4, 893 S. Delaware St., Indianapolis, IN, 46285, USA. pillay_sada_n@lilly.com., Baselga J; Medical Oncology, Vall d'Hebron, Barcelona, Spain. baselgaj@mskcc.org., Lahn MM; Eli Lilly and Company, Building 31/4, 893 S. Delaware St., Indianapolis, IN, 46285, USA. MichaLahn@aol.com.
Publikováno v:
Cardiovascular toxicology [Cardiovasc Toxicol] 2015 Oct; Vol. 15 (4), pp. 309-23.
Autor:
Rodon J; Medical Oncology, Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain. jrodon@vhio.net jrodon@vhebron.net., Carducci MA; Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland., Sepulveda-Sánchez JM; Hospital Universitario 12 de Octubre, Madrid, Spain., Azaro A; Medical Oncology, Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain., Calvo E; Medical Oncology, Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain., Seoane J; Medical Oncology, Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain., Braña I; Medical Oncology, Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain., Sicart E; Medical Oncology, Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain., Gueorguieva I; Eli Lilly and Company, Erl Wood, United Kingdom., Cleverly AL; Eli Lilly and Company, Erl Wood, United Kingdom., Pillay NS; Eli Lilly and Company, Indianapolis, Indiana., Desaiah D; Eli Lilly and Company, Indianapolis, Indiana., Estrem ST; Eli Lilly and Company, Indianapolis, Indiana., Paz-Ares L; Hospital Virgen del Rocío, Sevilla, Spain., Holdhoff M; Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland., Blakeley J; Department of Neurology/Neurosurgery/and Oncology, Johns Hopkins University, Baltimore, Maryland., Lahn MM; Eli Lilly and Company, Indianapolis, Indiana., Baselga J; Medical Oncology, Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Feb 01; Vol. 21 (3), pp. 553-60. Date of Electronic Publication: 2014 Nov 25.
Autor:
Cohn A; Rocky Mountain Cancer Center - Midtown, Denver, CO, USA., Lahn MM; Eli Lilly and Company, Indianapolis, IN, USA., Williams KE; Eli Lilly and Company, Indianapolis, IN, USA., Cleverly AL; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, UK., Pitou C; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, UK., Kadam SK; Eli Lilly and Company, Indianapolis, IN, USA., Farmen MW; Eli Lilly and Company, Indianapolis, IN, USA., Desaiah D; Eli Lilly and Company, Indianapolis, IN, USA., Raju R; Innovation Center Kettering Medical Center, Kettering, OH, USA., Conkling P; Virginia Oncology Associates, Norfolk, VA, USA., Richards D; Tyler Cancer Center, Tyler, TX, USA.
Publikováno v:
International journal of oncology [Int J Oncol] 2014 Dec; Vol. 45 (6), pp. 2221-31. Date of Electronic Publication: 2014 Sep 26.
Autor:
Gueorguieva I, Cleverly AL, Stauber A, Sada Pillay N, Rodon JA, Miles CP, Yingling JM, Lahn MM
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2014 May; Vol. 77 (5), pp. 796-807.